Heme synthesis inhibition induces the intrinsic apoptosis pathway in leukemia with OSGIN1 upregulation
Experimental Hematology · 2026
DOI: 10.1016/j.exphem.2026.105401 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Hematology, 2026. Verfasst von Yan Yan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Tohoku University Graduate School of Medicine, Sendai, Japan; Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, …. Hauptthemen laut MEDLINE: Apoptosis, Heme, Up-Regulation, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Princess Takamatsu Cancer Research Fund, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Acute myeloid leukemia (AML) is one of the hematologic malignancies with a poor outcome. AML has a unique metabolic status, and identifying its metabolic vulnerabilities is warranted. Recent genome-wide screenings suggest that heme synthesis might be such a vulnerability. Heme is required not only for hemoglobin synthesis but also for the proper function of hemoproteins. Cytochromes are such hemoproteins and are necessary for mitochondrial respiration. Therefore, heme synthesis inhibition can diminish AML by altering mitochondrial status and function. However, still little is known about the importance of heme synthesis in leukemia cells. To reveal the roles of heme synthesis in leukemia, we treated human leukemia cell lines with heme synthesis inhibitors, succinylacetone (SA) or N-methyl protoporphyrin IX (NMPP). Heme synthesis inhibition induced cell growth inhibition and cell death in a concentration-dependent manner. Therefore, heme synthesis is required for leukemia cell proliferation and survival. Increased proapoptotic factors (cleaved caspase 3 and cleaved PARP) and decreased antiapoptotic factor (XIAP) were observed following heme synthesis inhibition. Cytochrome c and Smac were released into the cytoplasm by heme synthesis inhibition, suggesting that heme synthesis inhibition led to mitochondrial outer membrane permeabilization and activation of the intrinsic pathway of apoptosis. Comprehensive transcriptomic analysis revealed that heme synthesis inhibition induced OSGIN1 expression, leading to the release of cytochrome c and Smac from mitochondria into the cytoplasm. Therefore, heme synthesis inhibition induced leukemia apoptosis by activating the intrinsic apoptosis pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Tohoku University Graduate School of Medicine, Sendai, Japan; Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, T…
- Department of Hematology, Tohoku University Graduate School of Medicine, Sendai, Japan. Electronic address: hiroki.kato.a5@tohoku.ac.jp.
- Department of Hematology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Förderung
- Princess Takamatsu Cancer Research Fund
- Japan Society for the Promotion of Science
Zitieren
APA
Yan, Y., Kato, H., Sano, S., Furukawa, E., Ichikawa, S., Onodera, K., Onishi, Y., Fukuhara, N., Yokoyama, H., Fujiwara, T., & Harigae, H. (2026). Heme synthesis inhibition induces the intrinsic apoptosis pathway in leukemia with OSGIN1 upregulation. Experimental Hematology. https://doi.org/10.1016/j.exphem.2026.105401
Vancouver
Yan Y, Kato H, Sano S, Furukawa E, Ichikawa S, Onodera K, et al. Heme synthesis inhibition induces the intrinsic apoptosis pathway in leukemia with OSGIN1 upregulation. Experimental Hematology. 2026. doi:10.1016/j.exphem.2026.105401
BibTeX
@article{Yan2026,
author = {Yan, Yan and Kato, Hiroki and Sano, Sayaka and Furukawa, Eijiro and Ichikawa, Satoshi and Onodera, Koichi and Onishi, Yasushi and Fukuhara, Noriko and Yokoyama, Hisayuki and Fujiwara, Tohru and Harigae, Hideo},
title = {Heme synthesis inhibition induces the intrinsic apoptosis pathway in leukemia with OSGIN1 upregulation},
journal = {Experimental Hematology},
year = {2026},
doi = {10.1016/j.exphem.2026.105401}
}
EUVIMED